Detection methods of multiple active ingredients in Maiweidihuang oral liquid

Through high-performance liquid chromatography, the problem of detecting ingredients of Maiwei Dihuang oral liquid was solved, and the quantitative detection of monoside, marcinoside and peony glycoside in Maiwei Dihuang oral liquid was realized, thereby improving the efficiency of quality control and accuracy, suitable for the quality evaluation and standard formulation of Maiwei Dihuang oral liquid.

CN118311171BActive Publication Date: 2024-11-01SHANDONG HANFANG PHARMA
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410462926.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-17
Publication Date
2024-11-01
Estimated Expiration
2044-04-17

AI Technical Summary

Technical Problem

The prior art cannot directly apply the quality control method of Maiwei Dihuang Pills to Maiwei Dihuang oral liquid, which makes it difficult to detect the effective ingredient of Maiwei Dihuang oral liquid, affecting its quality control and standard formulation.

Method used

Using high performance liquid chromatography, the content of monoside, marcinoside and peony glycoside in the oral liquid of Maiwei Dihuang was quantitatively detected by optimizing chromatographic conditions and test-product treatment methods, including filling with octadecylsilane bonded silica gel. Steps such as agent, gradient elution and methanol dilution.

Benefits of technology

It has achieved efficient detection of multiple active ingredients in Maiwei Dihuang oral liquid, improved the objectivity and accuracy of quality control, and is suitable for the quality evaluation and standard formulation of Maiwei Dihuang oral liquid.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118311171B_ABST
    Figure CN118311171B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of Chinese medicine component detection, and specifically relates to a method for detecting multiple effective components in Maiwei Dihuang oral liquid. The detection method comprises: (1) preparing a test solution; (2) preparing a mixed reference solution; (3) accurately aspirating the mixed reference solution and the test solution respectively, injecting them into a high performance liquid chromatograph, and recording a chromatogram; (4) calculating the content of each component in Maiwei Dihuang oral liquid according to the retention time and peak area of ​​the chromatogram of step (3). The detection method determines the contents of three components, morroniside, loganin, and paeoniflorin, through one chromatographic condition, and is more efficient and more suitable for the quality control of Maiwei Dihuang oral liquid.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicine component detection, and particularly relates to a method for detecting multiple effective components in Maiweidihuang oral liquid. Background Art

[0002] The current standard for Maiwei Dihuang oral liquid is included in the sixth volume of the Ministry of Health's drug standard for Chinese medicine formula preparations. This standard does not involve content determination standards. Therefore, in order to improve the quality control of Maiwei Dihuang oral liquid, it is necessary to obtain a content determination method for Maiwei Dihuang oral liquid.

[0003] In the Pharmacopoeia, there is a disclosure about the content determination of the drug Maiwei Dihuang Pills, and loganin and paeonol were used as reference substances for quality control. However, although the types of medicinal materials are the same in the composition of Maiwei Dihuang Pills and Maiwei Dihuang Oral Liquid, the proportion of each Chinese medicinal material is different. In addition, the preparation method of Maiwei Dihuang Pills does not involve extraction, but direct crushing of the medicinal materials. This results in different active ingredients in the two drugs, and the quality control method of Maiwei Dihuang Pills cannot be directly used for quality control of Maiwei Dihuang Oral Liquid.

[0004] In order to evaluate the quality of Maiwei Dihuang oral liquid more comprehensively and objectively, the present invention explores the determination conditions of Maiwei Dihuang oral liquid and realizes the simultaneous determination of the contents of three components, namely, morroniside, loganin and paeoniflorin, therein, which is more efficient and suitable for the quality control of Maiwei Dihuang oral liquid, and is of great significance in the quality evaluation and quality standard formulation of Maiwei Dihuang oral liquid. Summary of the invention

[0005] In order to solve the above problems, a method for detecting multiple effective ingredients in Maiwei Dihuang oral liquid is provided. The detection method determines the contents of three ingredients, morroniside, loganin and paeoniflorin, under one chromatographic condition, is more efficient and more suitable for the quality control of Maiwei Dihuang oral liquid, and solves the problems existing in the prior art.

[0006] The present invention provides a method for detecting multiple effective ingredients in Maiwei Dihuang oral liquid, comprising the following steps:

[0007] (1) Preparation of test solution:

[0008] Accurately measure the Maiwei Dihuang oral liquid, place it in a volumetric bottle, add methanol to dilute to the mark, filter, and take the filtrate;

[0009] (2) Preparation of mixed reference solution:

[0010] Accurately weigh appropriate amounts of morroniside, loganin, and paeoniflorin, and add methanol to make a solution containing appropriate concentrations of morroniside, loganin, and paeoniflorin per 1 ml;

[0011] (3) Accurately pipette the mixed reference solution and test solution separately, inject them into the high performance liquid chromatograph, and record the chromatogram;

[0012] (4) Calculate the content of each component in the Maiwei Dihuang oral liquid according to the retention time and peak area of ​​the chromatogram of step (3).

[0013] Furthermore, the chromatographic conditions of the high performance liquid chromatograph in step (3) are as follows: octadecylsilane bonded silica gel is used as a filler; mobile phase A is acetonitrile, mobile phase B is 0.1%-0.3% phosphoric acid solution, and gradient elution is performed according to the conditions in the following table; the detection wavelength is 230nm-240nm; the column temperature is 25°C-35°C; the flow rate is 0.9-1.1ml per minute;

[0014]

[0015] Furthermore, the mobile phase B is 0.3% phosphoric acid solution, and the gradient elution is performed according to the conditions in the following table; the detection wavelength is 240 nm; the column temperature is 30° C.; the flow rate is 1.0 ml per minute;

[0016]

[0017] Furthermore, the preparation method of the test solution is: accurately measure 1 ml of Maiwei Dihuang oral liquid, put it in a 10 ml volumetric bottle, add methanol to dilute to the scale, filter, and take the filtrate to obtain.

[0018] Furthermore, in the preparation of the test solution, after dilution with methanol, the solution is extracted by shaking or ultrasonic extraction, and then filtered after being taken out.

[0019] Furthermore, the period of shaking extraction or ultrasonic extraction is 30 minutes.

[0020] Furthermore, the preparation of the mixed reference solution is as follows: accurately weigh each reference substance, add methanol to prepare a mixed reference solution containing 40.0 ug / ml of morroniside, 20.0 ug / ml of loganin and 20.0 ug / ml of paeoniflorin per 1 ml.

[0021] Furthermore, the above-mentioned mixed reference solution was prepared as follows: accurately weigh each reference substance, and add methanol to each reference substance to prepare a reference substance mother solution containing 0.2023 mg / ml of morroniside, 0.2220 mg / ml of loganin, and 0.1937 mg / ml of paeoniflorin; an appropriate amount of solution was taken from each reference substance mother solution, and the solution was diluted and mixed to a certain extent with methanol to prepare a mixed reference substance solution containing 40.0 ug / ml of morroniside, 20.0 ug / ml of loganin and 20.0 ug / ml of paeoniflorin per 1 ml.

[0022] Furthermore, the volume concentration of methanol is 30%-100%, preferably 50%.

[0023] The beneficial effects of the present invention include but are not limited to:

[0024] 1. The present invention provides a method for detecting multiple effective ingredients in Maiwei Dihuang oral liquid. By exploring the method for determining the content of each component in Maiwei Dihuang oral liquid, the optimal mobile phase composition, gradient elution conditions, column temperature, and detection wavelength are screened through a large number of experiments. At the same time, the sample processing method is investigated, and finally a method for quantitatively detecting and determining three components such as morroniside is obtained.

[0025] 2. Since this detection method can simultaneously and quantitatively detect the three components of morroniside, loganin and paeoniflorin in Maiwei Dihuang oral liquid, it has higher detection efficiency and achieves the purpose of more objective, comprehensive and accurate evaluation of the quality of Maiwei Dihuang oral liquid. It is of great significance to the quality evaluation and quality standard formulation of Maiwei Dihuang oral liquid.

[0026] 3. The detection method of the present invention is easy to operate and has good specificity, stability, precision and repeatability. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:

[0028] Figure 1 It is a chromatogram of organic phase inspection in the HPLC chromatographic condition optimization experiment of the present invention;

[0029] Figure 2 The chromatograms of different acid concentrations in the HPLC chromatographic condition optimization experiment of the present invention are investigated;

[0030] Figure 3 The chromatograms of different gradients in the HPLC chromatographic condition optimization experiment of the present invention are as follows;

[0031] Figure 4 Investigating chromatograms at different detection wavelengths in the HPLC chromatographic condition optimization experiment of the present invention;

[0032] Figure 5 This is a chromatogram of the test for the specificity investigation of the present invention;

[0033] Figure 6 It is the result diagram of the linear relationship test of the present invention.

[0034] in, Figure 1 A-methanol; B-acetonitrile;

[0035] Figure 2 A-0.1% phosphoric acid; B-0.2% phosphoric acid; C-0.3% phosphoric acid;

[0036] Figure 3 A-12min organic phase ratio is 14; B-12min organic phase ratio is 15; C-12min organic phase ratio is 16;

[0037] Figure 4 A and B are chromatograms at detection wavelengths of 230nm and 240nm respectively;

[0038] Figure 5 AC in the middle are the chromatograms of blank, reference solution, and test solution of Maiwei Dihuang oral solution, respectively;

[0039] Figure 6 AC in the figure are the linear relationship diagrams of morroniside, loganin and paeoniflorin, respectively. DETAILED DESCRIPTION

[0040] The present invention is further described below in conjunction with specific embodiments, but the protection scope of the present application is not limited to these embodiments.

[0041] The detection method of multiple active ingredients in Maiwei Dihuang oral liquid provided in this embodiment is specifically described as follows:

[0042] 1. Instruments, reagents and drugs:

[0043] 1.1 Instruments: Agilent 1260 high performance liquid chromatograph; ultrapure water machine (Millipore); electronic balance (Mettler); digital ultrasonic cleaner (power 500W, Kunshan Ultrasonic Instrument Co., Ltd.)

[0044] Chromatographic column: The chromatographic column is Aglient 5TC-C18(2), 4.6mm×250mm, 5μm.

[0045] 1.2 Reagents: Methanol and acetonitrile were of chromatographic grade; other reagents were of analytical grade; water was ultrapure water.

[0046] 1.3 Drugs:

[0047] 1.3.1 Reference substances:

[0048] Morroniside reference substance (batch number: 111998-202205, source: China Food and Drug Inspection Institute, purity, 98.4%);

[0049] Loganin reference substance (batch number: 111640-201808, source: China Food and Drug Inspection Institute, purity, 99.0%);

[0050] Paeoniflorin reference substance (batch number: 110736-202145, source: China Food and Drug Inspection Institute, purity: 94.6%).

[0051] 1.3.2 Test products

[0052] Maiwei Dihuang oral liquid (batch number: 2023040101, source: homemade).

[0053] 1.3.3 Blank solution: 50% methanol.

[0054] 2. HPLC (High Performance Liquid Chromatography) Chromatographic Conditions:

[0055] Octadecylsilane bonded silica gel was used as the filler (Aglient 5TC-C18(2), 4.6 mm×250 mm, 5 μm or a chromatographic column of equivalent performance); acetonitrile was used as the mobile phase A, 0.3% phosphoric acid solution was used as the mobile phase B, and gradient elution was performed according to the provisions in Table 1; the detection wavelength was 240 nm; the column temperature was 30° C.; and the flow rate was 1.0 ml per minute.

[0056] Table 1 Gradient elution conditions

[0057]

[0058] 3. Preparation of mixed reference solution

[0059] Accurately weigh each reference substance, add methanol to prepare reference substance mother solutions of 0.2023 mg / ml of morroniside, 0.2220 mg / ml of loganin, and 0.1937 mg / ml of paeoniflorin; take an appropriate amount of solution from each reference substance mother solution, dilute and mix to a certain extent with methanol, and prepare a mixed reference substance solution containing 40 μg / ml of morroniside, 20 μg / ml of loganin, and 20 μg / ml of paeoniflorin per 1 ml.

[0060] 4. Preparation of test solution:

[0061] The preparation method of the test solution provided in this embodiment is as follows: accurately measure 1 ml of the sample, place it in a 10 ml volumetric flask, add 50% methanol to dilute to the scale, shake well, filter, and take the filtrate to obtain the solution.

[0062] 5. Optimization of HPLC Chromatographic Conditions

[0063] 5.1 Chromatographic conditions and system suitability test

[0064] Octadecylsilane bonded silica gel was used as filler; acetonitrile-0.3% phosphoric acid was used as mobile phase, and the detection wavelength was 230 nm.

[0065] 5.2 Investigation of the organic phase

[0066] The test sample was eluted with methanol and acetonitrile as the organic phase in a large gradient. According to the previous experiments, the test sample could be completely eluted when the proportion of the organic phase was about 50%.

[0067] Table 2

[0068]

[0069] See also Figure 1 ,According to the chromatogram of the sample, acetonitrile has a significantly better separation effect than methanol. Based on the large gradient, the gradient was refined to improve the separation effect of the chromatographic peaks of loganin, morroniside and paeoniflorin.

[0070] 5.3 Investigation of the aqueous phase (different acid concentrations)

[0071] Acetonitrile was used as the organic phase, and 0.1% phosphoric acid, 0.2% phosphoric acid and 0.3% phosphoric acid were used as the aqueous phase for injection, respectively. The specific gradients are shown in Table 3 Content Determination Gradient 1.

[0072] Table 3

[0073]

[0074] From the chromatogram of the test sample ( Figure 2 ) It can be seen that under different acid concentration conditions, the chromatographic peaks of loganin, morroniside and paeoniflorin in the chromatogram have no obvious changes, and the separation degree of loganin in the chromatogram obtained with 0.3% phosphoric acid is better.

[0075] 5.4 Organic phase ratio in different mobile phases

[0076] The gradient in Table 3 above can meet the requirements of content determination. In order to find better chromatographic conditions, the proportion of organic phase was investigated, and the gradient is as follows:

[0077] Table 4 Assay gradient 2

[0078]

[0079] Table 5 Assay gradient 3

[0080]

[0081] From the chromatogram of the test sample ( Figure 3 ) It can be seen that when the 12min organic phase ratio is 14, the separation degree between loganin and the next peak is <1.5; when the 12min organic phase ratio is 16, the separation degree between morroniside and the previous peak is <1.5, and when the 12min organic phase ratio is 15, the peak shape and separation degree of loganin, morroniside and paeoniflorin chromatographic peaks are all good. Therefore, Table 3 Gradient 1 is tentatively set as the elution gradient for the determination of loganin, morroniside and paeoniflorin content, and the specificity of the method and the durability of column temperature and flow rate are investigated.

[0082] 5.5 Flow rate durability investigation

[0083] Accurately pipette 10 μl of the test solution and inject it into the liquid chromatograph at flow rates of 0.9 ml / min, 1.0 ml / min and 1.1 ml / min, and record each chromatogram.

[0084] According to the measurement results, under the flow rates of 0.9ml / min, 1.0ml / min and 1.1ml / min, there were no significant differences in the chromatographic peak shapes and separation effects of loganin, morroniside and paeoniflorin.

[0085] 5.6 Column temperature durability study

[0086] Accurately pipette 10 μl of the test solution and inject it into the liquid chromatograph at column temperatures of 25°C, 30°C and 35°C, and record each chromatogram.

[0087] According to the measurement results, under the column temperature of 25℃ and 30℃, the chromatographic peak shape and separation effect of loganin, morroniside and paeoniflorin are better than those under the column temperature of 35℃.

[0088] 5.7 Determination of detection wavelength

[0089] According to the chromatographic conditions for content determination of loganin, morroniside, paeoniflorin and their formula preparations in the pharmacopoeia, combined with the absorption spectra of the chromatographic peaks of loganin, morroniside and paeoniflorin, the peak areas of loganin and morroniside increase at a wavelength of 240nm, while the peak area of ​​peoniflorin decreases. The difference between the peak areas of loganin at 230nm and 240nm is large, while the difference between the peak areas of morroniside and paeoniflorin at the two wavelengths is small, see Figure 4 . The wavelength is determined to be: 240nm.

[0090] Based on the above results, the chromatographic conditions of the present invention were determined.

[0091] VI. Inspection of test products

[0092] The present invention has carried out the following research on the test sample processing method.

[0093] 6.1 Investigation of the extraction solvent of the test sample

[0094] Accurately measure 1 ml of this product and place it in a 10 ml volumetric flask. Add 30% methanol, 50% methanol, 70% methanol and methanol, 30% ethanol, 50% ethanol, 70% ethanol and ethanol to dilute to the scale, shake well, filter, and take the filtrate to obtain the product.

[0095] Take the above test solution and filter it, take the filtrate and inject it. Determine the optimal test sample extraction solvent based on the peak area, peak shape and overall coordination of each characteristic peak.

[0096] The results showed that when the extraction solvent was ethanol, the peak shape of the spectrum was poor; when the extraction solvent was methanol of various concentrations, the peak shapes were better and there was no significant difference in the content of each component.

[0097] 6.2 Investigation of the extraction method of the test sample

[0098] Accurately measure 1 ml of this product, place it in a 10 ml volumetric flask, accurately add 50% methanol to dilute to the scale, shake to extract, ultrasonically extract for 30 minutes, take out, shake well, and obtain.

[0099] Take the above test solution and filter it, take the filtrate and inject it. Determine the optimal test sample preparation method based on the component content and overall coordination. The results show that there is no significant difference in the content of each component between shaking extraction and ultrasonic extraction.

[0100] 6.3 Investigation of extraction solvent dosage

[0101] Accurately measure 1 ml of this product and place it in a 10 ml or 25 ml volumetric flask. Accurately add 50% methanol to dilute to the scale, shake well, filter, and take the filtrate to obtain the product.

[0102] The results showed that there was no significant effect on the content of each component of the test sample.

[0103] VII. Methodological Investigation:

[0104] 7.1 Specificity test

[0105] Accurately pipette 10 μL of blank solution, mixed reference solution, and test solution respectively, and inject them according to the chromatographic conditions in "Part 2" above, and record the chromatograms. Figure 5 The peak positions of loganin, morroniside and paeoniflorin in the spectrum of the test solution are consistent with those in the spectrum of the mixed reference solution, and the peaks are well separated, indicating that the method has good specificity.

[0106] 7.2 Linear relationship test

[0107] Take appropriate amount of each reference substance mother solution in "three", dilute and mix to a certain extent with 50% methanol, and obtain 6 groups of mixed reference substance solutions with the following concentrations: morroniside 11.32, 22.63, 45.26, 67.90, 90.53, 113.16μg / ml, loganin 5.79, 11.58, 23.17, 38.61, 57.92, 77.22μg / ml, paeoniflorin 6.35, 12.70, 25.41, 42.34, 63.51, 84.69μg / ml, and inject and measure under the chromatographic conditions in "two". With peak area as ordinate (y) and injection concentration as abscissa (x), linear regression (n=6) was performed, and the results were shown in Table 6. See the linear relationship diagram for details. Figure 6 .

[0108] Table 6 Linear relationship test results

[0109] Reference substance name Linear Relationship <![CDATA[R 2 ]]> Linear range (ug) Morroniside y=16.168x+14.55 0.9995 11.32 μg / mL~113.16 μg / mL Loganin y=15.197x+4.3132 1.0000 5.79 μg / mL~77.22 μg / mL Paeoniflorin y=9.563x-2.194 1.0000 6.35 μg / mL~84.69 μg / mL

[0110] Conclusion: The results show that the linear relationship of each reference substance is good within the corresponding concentration range.

[0111] 7.3 Precision test

[0112] The mixed reference solution of the third mass concentration of each component under item "7.2" was accurately aspirated and measured 6 times according to the chromatographic conditions under item "II". The RSDs of the peak areas of morroniside, loganin and paeoniflorin were measured to be 1.01%, 0.93% and 1.38% (n=6), respectively, indicating that the instrument had good precision.

[0113] Table 7 Precision test results

[0114]

[0115]

[0116] 7.4 Repeatability test

[0117] Take the sample to be tested, prepare 6 test solutions in parallel according to the method under item "IV", and measure them according to the chromatographic conditions under item "II". The RSDs of morroniside, loganin and paeoniflorin were 0.45%, 0.60% and 0.57%, respectively, indicating that the method has good repeatability.

[0118] Table 8 Morroniside repeatability test results

[0119]

[0120] Table 9 Loganin repeatability test results

[0121]

[0122] Table 10 Paeoniflorin repeatability test results

[0123]

[0124]

[0125] 7.5 Stability test

[0126] The test solution of Maiwei Dihuang oral liquid was taken and measured according to the chromatographic conditions under item "two" at 0, 2, 4, 8, 12, 18, and 24 hours, and the RSDs of the peak areas of morroniside, loganin, and paeoniflorin were measured to be 0.16%, 0.54%, and 0.68%, respectively, indicating that the test solution had good stability within 24 hours.

[0127] Table 11 Morroniside stability test results

[0128]

[0129] Table 12 Loganin stability test results

[0130]

[0131] Table 13 Paeoniflorin stability test results

[0132]

[0133]

[0134] 7.6 Sample recovery experiment

[0135] Take 6 samples of Maiwei Dihuang oral liquid with known content of each component, and prepare 6 test solutions in parallel according to the method under "IV". Accurately measure 0.5mL of each solution into a 10mL volumetric flask, accurately add appropriate amount of reference substance mother solution [morroniside (0.2023mg / mL), loganin (0.2220mg / mL), paeoniflorin (0.1937mg / mL)], make up to the scale with 50% methanol, shake well, filter, take the filtrate, and measure according to the chromatographic conditions under "II". Calculate the recovery rate. The results are shown in Table 14, indicating that this method has a good recovery rate.

[0136] Table 14 Sample recovery test results

[0137]

[0138] The above is only the embodiment of the present application, and the protection scope of the present application is not limited by these specific embodiments, but is determined by the claims of the present application. For those skilled in the art, the present application can have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the technical ideas and principles of the present application should be included in the protection scope of the present application.

Claims

1. A method for detecting multiple active ingredients in Maiwei Dihuang oral liquid, characterized in that: The following steps are involved: (1) Preparation of test solution: Accurately measure the Maiwei Dihuang oral liquid, place it in a volumetric bottle, add methanol to dilute to the mark, filter, and take the filtrate; (2) Preparation of mixed reference solution: Accurately weigh appropriate amounts of morroniside, loganin, and paeoniflorin, and add methanol to prepare a solution containing appropriate concentrations of morroniside, loganin, and paeoniflorin per 1 ml; (3) Accurately pipette the mixed reference solution and test solution respectively, inject into the HPLC, and record the chromatogram; the chromatographic conditions of the HPLC are as follows: octadecylsilane bonded silica gel as filler; mobile phase A is acetonitrile, mobile phase B is 0.3% phosphoric acid solution, and gradient elution is performed according to the conditions in the table below; the detection wavelength is 240 nm; the column temperature is 30°C; and the flow rate is 1.0 ml per minute; (4) Calculate the content of each component in Maiwei Dihuang oral liquid based on the retention time and peak area of ​​the chromatogram in step (3).

2. The method for detecting multiple active ingredients in Maiwei Dihuang oral liquid according to claim 1, characterized in that: The preparation method of the test solution is as follows: accurately measure 1 ml of Maiwei Dihuang oral liquid, place it in a 10 ml volumetric bottle, add methanol to dilute to the scale, filter, and take the filtrate to obtain the test solution.

3. The method for detecting multiple active ingredients in Maiwei Dihuang oral liquid according to claim 2, characterized in that: In the preparation of the test solution, dilute it with methanol, extract it by shaking or ultrasonic extraction, then take it out and filter it.

4. The method for detecting multiple active ingredients in Maiwei Dihuang oral liquid according to claim 3, characterized in that: The period of shaking extraction or ultrasonic extraction is 30 min.

5. The method for detecting multiple active ingredients in Maiwei Dihuang oral liquid according to claim 1, characterized in that: The preparation of the mixed reference solution is as follows: accurately weigh each reference substance, add methanol to prepare a mixed reference solution containing 40.0 ug / ml of morroniside, 20.0 ug / ml of loganin and 20.0 ug / ml of paeoniflorin per 1 ml.

6. The method for detecting multiple active ingredients in Maiweidihuang oral liquid according to any one of claims 1-3 and 5, characterized in that: The volume concentration of methanol is 30%-100%.

7. The method for detecting multiple active ingredients in Maiwei Dihuang oral liquid according to claim 6, characterized in that: The volume concentration of methanol is 50%.

Citation Information

Patent Citations

  • Multicomponent quantitative detection method of lycium-rehmannia oral liquid

    CN108562681A

  • Method for detecting specific chromatogram of compound golden cypress liquid preparation

    CN110716001A

  • HPLC (High Performance Liquid Chromatography) method for simultaneously determining eight effective components in six-ingredient rehmannia pills

    CN111650306A

  • Method for controlling quality of prepared rehmannia root in rehmannia pill formula preparation

    CN116626204A